Keyphrases
Acute Pancreatitis
11%
Asia
8%
Asian Countries
9%
Bleeding
8%
Chronic Diarrhea
13%
Clinical Manifestations
9%
Colon
8%
Colonoscopy
12%
Colorectal Cancer
15%
Confidence Interval
9%
COVID-19
25%
COVID-19 Pandemic
12%
Crohn's Disease
9%
Diarrhea
9%
Dyspepsia
32%
East Asia
8%
East Asian Countries
8%
Endoscopic Retrograde Cholangiopancreatography
13%
Endoscopy
21%
Functional Constipation
8%
Gastric Cancer
19%
Gastric mucosa
12%
Gastritis
10%
Gastroenterology
8%
Gastroesophageal Reflux Disease
34%
Gastrointestinal Diseases
8%
Gastrointestinal Endoscopy
12%
Helicobacter Pylori (H. pylori)
77%
Helicobacter Pylori Eradication
11%
Helicobacter Pylori Infection
70%
Histopathological Examination
10%
Indonesia
100%
Indonesian
28%
Indonesian Population
9%
Inflammatory Bowel Disease
17%
Irritable Bowel Syndrome
11%
Jakarta
36%
Malignancy
12%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
8%
Obesity
11%
Peptic Ulcer
8%
Proton Pump Inhibitors
15%
Questionnaire Survey
8%
Risk Factors
25%
Rome Foundation
10%
Tuberculosis
9%
Upper Gastrointestinal Bleeding
9%
Upper Gastrointestinal Tract
9%
Urea Breath Test
8%
Young Males
9%
Medicine and Dentistry
Abdominal Cancer
20%
Acute Pancreatitis
11%
Amyloidosis
6%
Biliary Tract Drainage
8%
Biological Marker
7%
Biopsy Technique
11%
Bleeding
11%
Cancer
13%
Cholestasis
12%
Chronic Diarrhea
13%
Colitis
9%
Colon
9%
Colonoscopy
16%
Colorectal Cancer Screening
6%
Colorectal Carcinoma
10%
Colorectal Polyp
7%
COVID-19
31%
Crohn's Disease
9%
Cross Sectional Study
15%
Diarrhea
15%
Diseases
29%
Endoscopic Retrograde Cholangiopancreatography
14%
Endoscopy
16%
Esophagus
8%
functional dyspepsia
9%
Functional Gastrointestinal Disorder
7%
Gastritis
13%
Gastroenterology
7%
Gastroesophageal Reflux
33%
Gastrointestinal Endoscopy
12%
Gastrointestinal Tract
6%
Helicobacter Infection
49%
Helicobacter Pylori
55%
Histopathology
10%
Infection
28%
Inflammatory Bowel Disease
17%
Irritable Bowel Syndrome
8%
Jejunum Ulcer
6%
Neoplasm
7%
Obstructive Jaundice
8%
Pathophysiology
7%
Polyp
8%
Prevalence
31%
Proton-Pump Inhibitor
7%
Quality of Life
7%
Stenting
7%
Stomach Acid
29%
Stomach Mucosa
9%
Upper Gastrointestinal Bleeding
8%
Urea Breath Test
10%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
14%
Adverse Event
5%
Antibiotics
9%
Antimicrobial Resistance
5%
Bleeding
7%
Chronic Diarrhea
5%
Clarithromycin
9%
Colorectal Carcinoma
19%
Coronavirinae
7%
Crohn's Disease
5%
Cross-Sectional Study
14%
Diabetes Mellitus
6%
Diarrhea
7%
Diseases
30%
Gastric Mucosa
7%
Gastritis
11%
Gastroesophageal Reflux
25%
Helicobacter Infection
46%
Helicobacter Pylori
65%
Ileum
6%
Infection
28%
Inflammation
6%
Inflammatory Bowel Disease
9%
Jejunum Ulcer
7%
Levofloxacin
6%
Malignant Neoplasm
8%
Metronidazole
9%
Non-Steroidal Anti-Inflammatory Drug
9%
Peptic Ulcer
7%
Polyp
5%
Prevalence
46%
Proton Pump Inhibitor
11%
Reflux Esophagitis
5%
Retrospective Study
5%
SARS Coronavirus
5%
Stomach Acid
24%
Stomach Disorders
5%
Stomach Ulcer
6%
Upper Gastrointestinal Bleeding
8%
Urea Breath Test
6%